Internal Medicine, Infectious Disease · San Antonio, TX
NPI
1265797690
Since 2012
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
720 Pleasanton Rd
San Antonio, TX, 78214
Phone (210) 921-3800
Groups this clinician bills Medicare through
Medicare paid, 2024
$9,375
139 services
Medicare patients, 2024
39
Average age 75
Drug cost, 2024
$4.9M
13,092 prescriptions
Company payments, 2025
$1,147
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Norys A Castro Pena was code 99214 (office e&m - established), 83 times for 36 patients. In total Norys A Castro Pena billed 139 services in 26 codes, and Medicare paid $9,375.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-10-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 83 | 36 | $85.10 | $7,064 |
By year: 2022 $13K for 305 services; 2023 $11K for 172 services; 2024 $9,375 for 139 services.
Medicare prescription drug claims, 2024
In 2024, the drug Norys A Castro Pena prescribed most often to Medicare patients was Rosuvastatin Calcium, with 787 prescriptions and refills. In total Norys A Castro Pena wrote 13,092 Medicare prescriptions that cost $4.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 787 | 2,267 | 258 | $11K |
| Atorvastatin Calcium Generic | 517 | 1,513 | 170 | $5,792 |
| Lisinopril Generic | 428 | 1,250 | 129 | $3,561 |
| Gabapentin Generic | 417 | 863 | 141 | $7,851 |
| Levothyroxine Sodium Generic | 331 | 947 | 90 | $2,405 |
| Cephalexin Generic | 328 | 897 | 127 | $9,380 |
| Metformin Hcl Generic | 323 | 961 | 108 | $2,506 |
| Amlodipine Besylate Generic | 281 | 826 | 97 | $1,669 |
| Losartan Potassium Generic | 276 | 837 | 93 | $2,791 |
| Tramadol Hcl Generic | 240 | 240 | 50 | $2,442 |
| Omeprazole Generic | 201 | 562 | 67 | $5,444 |
| Ozempic Semaglutide | 198 | 248 | 45 | $221K |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 192 | 547 | 79 | $2,043 |
| Gemtesa Vibegron | 184 | 449 | 68 | $215K |
| Dovato Dolutegravir Sodium/Lamivudine | 183 | 191 | 22 | $588K |
Brand drugs: 2,693 claims; generic drugs: 10,313 claims; opioid claims: 367.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Norys A Castro Pena $1,147 ($1,147 in general payments such as food, travel and fees) from 10 companies. The largest payer was Gilead Sciences, Inc. with $332.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 7 | $332 |
| ViiV Healthcare Company GSK | 14 | $289 |
| Abbvie Inc. ABBV | 11 | $176 |
| Merck Sharp & Dohme LLC MRK | 2 | $137 |
| Abbott Laboratories ABT | 2 | $49.58 |
| Pfizer Inc. PFE | 3 | $47.31 |
| Lundbeck LLC | 2 | $46.11 |
| Novo Nordisk Inc NVO | 2 | $35.75 |
| Cipher Pharmaceuticals US LLC CPH.TO | 1 | $20.7 |
| Astellas Pharma US Inc 4503.T | 1 | $14.54 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.